Biogelx is Specialty Chemicals in United Kingdom that focus on cancer cell research business. Founded in 2012. They cover business area such as developer, tuneable peptide hydrogel, bioink, bioprinting, application, cell culture research, cell-base toxicity screening, cancer cell research, animal testing, cell therapy, regenerative medicine, academic user, medical researcher, pharmaceutical company, manipulate cell.
2012
( 14 years old in 2026 )
Cancer Cell Research
-
BioCity Scotland, Bo'Ness Road
Newhouse
Lanarkshire ML1 5UH
Scotland, United Kingdom
Private
developertuneable peptide hydrogelbioinkbioprintingapplicationcell culture research, cell-base toxicity screeningcancer cell researchanimal testingcell therapyregenerative medicineacademic usermedical researcherpharmaceutical companymanipulate cell
* We use standard office opening hours in near Biogelx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Biogelx is Specialty Chemicals business from United Kingdom that founded in 2012 (14 years old in 2026), Biogelx business is focusing on Cancer Cell Research.
Biogelx headquarter office and corporate office address is located in BioCity Scotland, Bo'Ness Road Newhouse Lanarkshire ML1 5UH Scotland, United Kingdom.
Biogelx was founded in United Kingdom.
In 2026, Biogelx is currently focus on cancer cell research sector.
Above is snippet of Google Trends for "cancer cell research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Biogelx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
